Photodynamic Therapy-Induced Immune Modulation: Part III

NCT03643744 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Per PI due to data analysis results.

Conditions

Actinic Keratosis
Photodynamic Therapy

Interventions

DRUG: Celecoxib 200mg
DRUG: Placebo

Sponsor

Wright State University